Grenoble, France, 28th January 2013 – CYTOO, a life science systems & tools company providing disruptive
solutions for cell-based assays and High Content Screening (HCS), will attend the Biophysical Society (BPS)
57th Annual Meeting in Philadelphia, Pennsylvania, USA to present its innovative Cell Culture Platform,
based on adhesive micropatterns. After the recent launch of the CYTOOplates Motility, specifically
designed to study cell migration for screening applications in both oncology and drug discovery, the
company has the great pleasure to sponsor the Motility subgroup.
The Biophysical Society’s subgroups allow members to meet and interact within more focused areas in
smaller groups. Subgroups hold scientific symposia and business meetings each year on Saturday preceding
the start of the Annual Meeting. The mission of the Motility Subgroup is to understand the basic
mechanisms that underlie motility and contractility of biological systems.
CYTOO is delighted to have the opportunity to present the Motility products and their unique
characteristics to the subgroup members. To celebrate the first anniversary of the World Cell Race1, CYTOO
launched in December the CYTOOplates Motility, the microplate version of the CYTOOchips Motility, a
perfect tool for studying cell migration, showing characteristics closer to those found in vivo2.
CYTOO’s Motility products feature adhesive tracks of 4 different widths from 2.5 to 20 µm allowing a wide
range of applications including single vs collective cell migration, cell pairing, and in other application
areas, such as directional neurite outgrowth assays.
Attendees are invited to visit BPS booth #650 to discover the Motility products, and to discuss their 2D+
application with Alexandra Fuchs, PhD, COO, and Yoran Margaron, PhD, Research Scientist.
1. Maiuri P, Terriac E, Paul-Gilloteaux P, et al. The first World Cell Race. Curr Biol. 2012;22(17):R673-
2. Sharma V, Beaty B, Patsialou A, et al. Reconstitution of in vivo macrophage-tumor cell pairing and
streaming motility on one-dimensional micro-patterned substrates. IntraVital. 2012;1(1):77-85.
For more information, visit www.cytoo.com/BPS2013
Alexandra Fuchs, PhD, COO
firstname.lastname@example.org, +33 (0)4 38 88 47 07
About CYTOO S.A.
CYTOO is a distinctive life sciences systems & tools company offering disruptive solutions for cell-based assays and
High Content Screening (HCS) that reinforce robustness, sensitivity and powerful quantification. The Company’s 2D+
Cell Culture Platform and Custom Solutions are based on adhesive micropatterns, offering control over the cells'
microenvironment, leading to normalized cell morphology and behavior. The technology allows the optimization or
resurrection of complex or difficult cell-based assays and enables innovative assay development.
For more information about the complete product portfolio, visit www.cytoo.com